In SCA1, SCA2, FRDA and MSA-Cpatients, there was a significant reduction in DNsil but much smallercompared with SCA6 patients (Row 6, Fig.1 and Supplementary Figs 3–5). The gene discussed is FXN; the disease is multiple system atrophy.